Extranodal NK-T-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(11 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{{Extranodal NK-T-cell lymphoma}}
{{Extranodal NK-T-cell lymphoma}}


{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{RG}}  


{{SK}} Angiocentric T cell lymphoma; Extranodal NK-T-cell lymphoma, nasal type; Extranodal NK-T-cell lymphoma, extra nasal type
{{SK}} Angiocentric T cell lymphoma; Extranodal NK-T-cell lymphoma, nasal type; Extranodal NK-T-cell lymphoma, extra nasal type
Line 12: Line 12:


==[[Extranodal NK-T-cell lymphoma historical perspective|Historical Perspective]]==
==[[Extranodal NK-T-cell lymphoma historical perspective|Historical Perspective]]==
==[[Extranodal NK-T-cell lymphoma classification|Classification]]==
==[[Extranodal NK-T-cell lymphoma classification|Classification]]==
==[[Extranodal NK-T-cell lymphoma pathophysiology|Pathophysiology]]==
==[[Extranodal NK-T-cell lymphoma pathophysiology|Pathophysiology]]==
==[[Extranodal NK-T-cell lymphoma causes|Causes]]==
==[[Extranodal NK-T-cell lymphoma causes|Causes]]==
==[[Extranodal NK-T-cell lymphoma differential diagnosis|Differentiating Extranodal NK-T-cell lymphoma from other Diseases]]==
==[[Extranodal NK-T-cell lymphoma differential diagnosis|Differentiating Extranodal NK-T-cell lymphoma from other Diseases]]==
==[[Extranodal NK-T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]==
==[[Extranodal NK-T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]==
==[[Extranodal NK-T-cell lymphoma risk factors|Risk Factors]]==
==[[Extranodal NK-T-cell lymphoma risk factors|Risk Factors]]==
==[[Extranodal NK-T-cell lymphoma screening|Screening]]==
==[[Extranodal NK-T-cell lymphoma screening|Screening]]==
==[[Extranodal NK-T-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[Extranodal NK-T-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==Diagnosis==
[[Extranodal NK-T-cell lymphoma diagnostic study of choice|Diagnostic study of choice]] | [[Extranodal NK-T-cell lymphoma history and symptoms|History and Symptoms]] | [[Extranodal NK-T-cell lymphoma physical examination|Physical Examination]] | [[Extranodal NK-T-cell lymphoma laboratory findings|Laboratory Findings]] | [[Extranodal NK-T-cell lymphoma electrocardiogram|Electrocardiogram]] | [[Extranodal NK-T-cell lymphoma x ray|X-Ray Findings]] | [[Extranodal NK-T-cell lymphoma echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Extranodal NK-T-cell lymphoma CT scan|CT-Scan Findings]] | [[Extranodal NK-T-cell lymphoma MRI|MRI Findings]] | [[Extranodal NK-T-cell lymphoma other imaging findings|Other Imaging Findings]] | [[Extranodal NK-T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]]


==Diagnosis==
[[Extranodal NK-T-cell lymphoma staging|Staging]] | [[Extranodal NK-T-cell lymphoma history and symptoms|History and Symptoms]] | [[Extranodal NK-T-cell lymphoma physical examination|Physical Examination]] | [[Extranodal NK-T-cell lymphoma laboratory findings|Laboratory Findings]] | [[Extranodal NK-T-cell lymphoma CT|CT]] | [[Extranodal NK-T-cell lymphoma MRI|MRI]] | [[Extranodal NK-T-cell lymphoma other imaging findings|Other Imaging Findings]] | [[Extranodal NK-T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Extranodal NK-T-cell lymphoma medical therapy|Medical Therapy]] | [[Extranodal NK-T-cell lymphoma surgery|Surgery]] | [[Extranodal NK-T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Extranodal NK-T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
[[Extranodal NK-T-cell lymphoma medical therapy|Medical Therapy]] | [[Extranodal NK-T-cell lymphoma interventions|Interventions]] | [[Extranodal NK-T-cell lymphoma surgery|Surgery]] | [[Extranodal NK-T-cell lymphoma primary prevention|Primary Prevention]] | [[Extranodal NK-T-cell lymphoma secondary prevention|Secondary Prevention]] | [[Extranodal NK-T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Extranodal NK-T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
==Case Studies==


Line 48: Line 39:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 12:57, 16 October 2019

For patient information, click here

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma

CDC on Extranodal NK-T-cell lymphoma

Extranodal NK-T-cell lymphoma in the news

Blogs on Extranodal NK-T-cell lymphoma

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Synonyms and keywords: Angiocentric T cell lymphoma; Extranodal NK-T-cell lymphoma, nasal type; Extranodal NK-T-cell lymphoma, extra nasal type


Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies


Treatment

Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1



Template:WikiDoc Sources